The book reopened on infectious diseases

Microbes and Infection

Volumn 10, Issue 9, 2008, Pages 942-947

  Avila, Maria ^a   Saïd, Najwane ^a   Ojcius, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

History; Infectious diseases; Pandemics; Pathogens; Worldwide

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; AVIATION; CLIMATE CHANGE; COWPOX; CRYPTOSPORIDIUM HOMINIS; DEMOGRAPHY; DRUG MISUSE; EBOLA VIRUS; ESCHERICHIA COLI; HEALTH CARE; HELICOBACTER PYLORI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNIZATION; INFECTION; INFLUENZA; LEGIONELLA PNEUMOPHILA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PANDEMIC; PATHOGENESIS; PENICILLIUM; PRIORITY JOURNAL; PUBLIC HEALTH; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SMALLPOX; SPANISH INFLUENZA; TUBERCULOSIS; URBANIZATION; VACCINATION; VIBRIO CHOLERAE; YERSINIA PESTIS;

CHRONIC DISEASE; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; PUBLIC HEALTH; VACCINATION; WORLD HEALTH;

EID: 53449099291     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.07.012     Document Type: Article

References (60)

1. Cohen M.L. Changing patterns of infectious disease. Nature 406 (2000) 762-767
2. McMichael A.J. Environmental and social influences on emerging infectious diseases: past, present, and future. In: McLean A.R., May R.M., Patterson J., and Weiss R.A. (Eds). SARS: A Case Study in Emerging Infections (2005), Oxford University Press, Oxford
3. Trends and Current Status in Childhood Mortality. United States 1900-85, National Center for Health and Statistics. Vital Health and Statistics Series 3 (1989)
4. Kuiken T., Leighton F.A., Fouchier R.A., LeDuc J.W., Peiris J.S., Schudel A., Stöhr K., and Osterhaus A.D. Public health. Pathogen surveillance in animals. Science 309 (2005) 1680-1681
5. 2007 AIDS epidemic update, Joint United Nations Programme on HIV/AIDS (UNAIDS) UNAIDS, 2007.
6. CDC. CDC's 60th Anniversary: Director's Perspective - David J. SencerM.D., M.P.H., 1966-1977. MMWR 55 (2006) 745-749
7. Krasner R.L. 20th Century Microbe Hunters. Jones and Bartlett Publishers (2008) Sudbury, Massachusetts
8. Barnes D. The Great Stink of Paris and the Nineteenth-Century Struggle against Filth and Germs (2006), The John Hopkins University Press, Baltimore
9. Reyburn W. Flushed with Pride: The Story of Thomas Crapper. Trafalgar Square Publishing (1991)
10. Brown K. Penicillin Man: Alexander Flemming and the Antibiotic Revolution (2004), Sutton Publishing, Stroug, England
11. Wolfe N.D., Panosian-Dunavan C., and Diamond J. Origins of major human infectious diseases. Nature 447 (2007) 279-283
12. Binder S., Levitt A.M., Snacks J.J., and Hughes J.M. Emerging infectious diseases: public health issues for the 21st Century. Science 284 (1999) 1311-1313
13. Weiss R.A. The Leeuwenhoek lecture 2001. Animal origins of human infectious diseases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 1410 (2001) 957-977
14. Zhou D., Han Y., and Yang R. Molecular and physiological insights into plague transmission, virulence and etiology. Microbes Infect. 8 (2006) 273-284
15. WHO. WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases - Plague, Epidemic and Pandemic Alert and Response (EPR) (2007), World Health Organization, Geneva
16. Pearce-Duvet J. The origin of human pathogens: evaluating the role of agriculture and domestic animals in the evolution of human disease. Biol. Rev. Camb. Philos. Soc. 81 (2006) 369-382
17. Zink A., Sola C., Reischl U., Grabner W., Rastogi N., Wolf H., and Nerlich A. Characterization of Mycobacterium tuberculosis complex DNAs from Egyptian mummies by spoligotyping. J. Clin. Microbiol. 41 (2003) 359-367
18. Onyebujoh P., and Rook G.A.W. Tuberculosis. Nat. Rev. Microbiol. 2 (2004) 930-932
19. Patterson K.D., and Pyle G.F. The geography and mortality of the 1918 influenza pandemic. Bull. Hist. Med. 65 (1991) 4-21
20. Mahalingam S., Damon I.K., and Lidbury B.A. 25 years since the eradication of smallpox: why poxvirus research is still relevant. Trends Immunol. 25 (2004) 636-639
21. Fenne F., Henderson D.A., Jezek Z., and Ladnyi I.D. Smallpox and its Eradication (1988), World Health Organization, Geneva
22. Mohamadzadeh M., Chen L., and Schmaljohn A.L. How Ebola and Marburg viruses battle the immune system. Nat. Rev. Immunol. 7 (2007) 556-567
23. Nabel G.J., Sullivan N.J., and Yong Yang Z. Cellular and molecular mechanisms of Ebola pathogenicity and approaches to vaccine development. In: Klenk H.-D. (Ed). Ebola and Marburg Viruses: Molecular and Cellular Biology (2004), The Cromwell Press, Wiltshire
24. Fraser D.W. The challenges were legion, Lancet Infect. Dis. 5 (2005) 237-241
25. Stanek G., Strle F., Gray J., and Wromser G.P. History and characteristics of Lyme Borreliosis. In: Gray J., Kahl O., Lane R.S., and Stanek G. (Eds). Lyme Borreliosis: Biology, Epidemiology and Control (2002), Cromwell Press, Trowbrisge
26. The World Health Report: a Safer Future: Global Public Health Security in the 21st Century (2007), World Health Organization, Geneva
27. Morens D.M., Folkers G.K., and Fauci A.S. The challenge of emerging and re-emerging infectious diseases. Nature 430 (2004) 242-249
28. Wang H., Feng Z., Shu Y., Yu H., Zhou L., Zu R., Huai Y., Dong J., Bao C., Wen L., Wang H., Yang P., Zhao W., Dong L., Zhou M., Liao Q., Yang H., Wang M., Lu W., Shi Z., Wang W., Gu L., Zhu F., Li Q., Yin W., Yang W., Uyeki T.M., and Wang Y. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 371 (2008) 1427-1434
29. Fonseca D.M., Keyghobadi N., Malcolm C.A., Mehmet C., Schaffner F., et al. Emerging vectors in the Culex pipiens complex. Science 303 (2004) 1535-1538
30. Levy E., and Fischetti M. The New Killer Diseases (2003), Crown Publishers Random House, New York
31. Bermingham A., Heinen P.P., Hurriza-Gomara M., Gray J.J., Appleton H., and Zambbon M.C. Laboratory diagnosis of SARS. In: McLean A.R., May R.M., Pattison J., and Weiss R.A. (Eds). SARS: A Case Study in Emerging Infections (2005), Oxford University Press
32. WHO, International Spread of Disease Threatens Public Health Security, 2007.
33. Merrell D.S., and Falkow S. Frontal and stealth attack strategies in microbial pathogenesis. Nature 430 (2004) 250-256
34. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II2-II10
35. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
36. CDC. Chronic Disease Prevention, Department of Health and Human Services. Georgia (2008)
37. Marks D.J., Mitchison N.A., Segal A.W., and Sieper J. Can unresolved infection precipitate autoimmune disease?. Curr. Top. Microbiol. Immunol. 305 (2006) 105-125
38. Hoofnagle J.H., and di Bisceglie A.M. The treatment of chronic viral hepatitis. New Engl. J. Med. 336 (1997) 347-356
39. Pagliusi S.R., Aguado M.T., and Parkin D.M. Possible worldwide impact of prevention of human papillomavirus. In: Garcea R.L., and DiMaio D. (Eds). The Papillomavirus (2007), Springer, New York
40. Ewald P.W. Evolution of virulence. Infect. Dis. Clin. North Am. 18 (2004) 1-15
41. Ewald P.W. Evolution of Infectious Disease (1994), Oxford University Press, Oxford
42. Campbell L.A., and Kuo C.C. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis?. Nat. Rev. Microbiol. 2 (2004) 23-32
43. Mussa F.F., Chai H., Wang X., Yao Q., Lumsden A.B., and Chen C. Chlamydia pneumoniae and vascular disease: an update. J. Vasc. Surg 43 (2006) 1301-1307
44. Confalonieri U., Menne B., Akhtar R., Ebi K.L., and Hauengue M. Climate change 2007: impacts, adaptation and vulnerability. In: Parry M.L., Canzani O.F., Palutikof J.P., and van der Linden P.J. (Eds). Human Health (2007), Cambridge University Press, Cambridge 391-431
45. Cohen A. Urban unfinished business, Int. J. Environ. Health 13 (2003) S13-S36
46. Hawkey P.M. Molecular epidemiology of clinically significant antibiotic resistance genes. Br. J. Pharmacol. 153 (2008) S406-S413
47. Hawkey P.M. The origins and molecular basis of antibiotic resistance. Brit. Med. J. 317 (1998) 657-660
48. Shah N.S., Wright A., Bai G.-H., Barrera L., Boulahbal F., Martín-Casabona N., et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 13 (2007) 380-387
49. Pablos-Mendez A., and Lessnau K. Clinical Mismanagement and Other Factors Producing Anti-tuberculosis Drug Resistance (2000), Kluwer Academic Publishers, Dordrecht
50. Pepper D.J., Meintjes G.A., McIlleron H., and Wilkinson R.J. Combined therapy for tuberculosis and HIV-1: the challenge for drug discovery. Drug Disc. Today 12 (2007) 980-989
51. Whitcomb J.M., et al. Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates. AIDS 16 (2002) F41-F47
52. Wu J., Yan P., and Archibald C. Modelling the evolution of drug resistance in the presence of antiviral drugs. BMC Public Health 7 (2007) 300
53. Patz J., Campbell-Lendrum D., Gibbs H., and Woodruff R. Health impact assessment of global change: risk assessment approaches for policy making. Annu. Rev. Public Health 29 (2008) 27-39
54. Karl T., and Trenberth K. Modern global climate change. Science 302 (2003) 1719-1723
55. Haines A., and Patz J. Health effects of climate change. JAMA 291 (2004) 99-103
56. McMichael A.J., et al. Chapter 20. In: Ezzati M., Lopez A.D., and Rogers A. (Eds). Comparative Quantification of Health Risks: Global and Regional Burden of Disease due to Selected Major Risk Factors (2004), World Health Organization, Geneva 1543-1649
57. Shope R. Global climate change and infectious diseases. Environ. Health Perspect 96 (1991) 171-174
58. Charrel R.N., de Lamballerie X., and Raoult D. Seasonality of mosquitoes and Chikungunya in Italy. Lancet Infect. Dis. 8 (2008) 5-6
59. Weissmann G. Gore's fever and Dante's Inferno: Chikungunya reaches Ravenna. FASEB J 22 (2008) 635-638
60. Purse B.V., Mellor P.S., Rogers D.J., Samuel A.R., Mertens P.P., and Baylis M. Climate change and the recent emergence of bluetongue in Europe. Nat. Rev. Microbiol. 3 (2005) 171-181